3Kim EH, Bird JA, Kulis M, et aI.Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensiti- zation [ J ] .J Allergy Clin Immum)l. 2011,127 ( 3 ) : 64-0-646.
4Schmit A, Carol M, Robert F, et al. Dose-effect of interleu- kin-10 and its immunoregulatory role in Cmhn' s disease [J ]. Eur Cytokine Netw, 2002, 13 ( 3 ) : 298-305.
5Kotlarz D, Beier R, Diestelhorst J, et al. l,oss of interleukin-10 signaling and infantile inflammatory" bowel disease-implications for diagnosis and therapy [J/OL]. [ 2012-4-28 ].Http://www.sci- encedi rect.com/sc i ence/articl e/pill/SO016508512006725 ? v---s5# FCANote.
7Saraiva M, O' Garra A. The regulation of ll,-lO production I)y immune cells[J j.Nat Rev lmmunol,2010, 10(3):170-181.
8Conti P, Kempuraj D, Kandere K, et al. IL-10: an inflamrnalo3'/ inhibitory eytokine, but not always [J ].lmmunol Lelt, 2003, 86 (2): 123-129.
9Mocellin S, Panelli MC, Wang E, et al. The dual role of IL-10 [ J ]. Trends lmmunol, 2003,24( 1 ) : 36-43.
10Commeren DL, Van Soest PI+, Karimi K, et al. Paradoxical el: fects of interleukin-10 on the maturation of murine myeloid dendritic cells[ J ].Immunology, 2003,110(2) : 188-196.
